Health
The CU Â鶹ӰԺ biochemist has been awarded for her career dedication to the study of nucleosomes and groundbreaking discoveries.
Toxic protein clusters known as tau aggregates underlie dozens of neurodegenerative diseases, or "tauopathies." New research illuminates why they form and spread and how to stop them.
Sanna Darvish discusses the interventions her research has identified to improve heart health and the steps the Integrative Physiology of Aging Laboratory has taken to address accessibility challenges for people in underrepresented groups.
New research shows that a little-known brain pathway plays a critical role in making pain last after tissue heals. The findings could help pave the way for new brain-machine interfaces and medications that ease suffering without the use of opioids.
CU Â鶹ӰԺ and two other CU campuses have been chosen from a nationwide search to partner with Medtronic—a global leader in health care technology—in a strategic research agreement aimed at accelerating transformative health innovations.
A new device, designed by researchers at CU Â鶹ӰԺ and CU Anschutz, jiggles red blood cells until they break apart—revealing valuable information about their quality.
The Nobel laureate and CU Â鶹ӰԺ professor, recently ranked #1 globally for RNA research, will speak at the World Economic Forum annual meeting in Davos, Switzerland Wednesday.
In an ongoing effort to bridge a pervasive investment gap in innovation funding, CU Â鶹ӰԺ has awarded pre-seed funding to Illumen Therapeutics, developing cancer treatments based on discoveries from startup co-founder Roy Parker's lab at CU Â鶹ӰԺ.
CU Â鶹ӰԺ scientist Roselinde Kaiser and research colleagues seek to understand the connection between executive functioning and mood problems.
A paper co-authored by CU Â鶹ӰԺ researcher Christopher Lowry draws upon the infamous "Twinkie defense" to explore the relationship between ultra-processed foods and human behavior.